Suchergebnisse - "Harenberg, Job"

PubPharm (12)

1

Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial

enthalten in: Thrombosis and haemostasis | 2020

von Harenberg, J. | Beyer-Westendorf, J. | Crowther, M. | +41

CommentIn: Thromb Haemost. 2020 Jan;120(1):11-13. - PMID 31752043

2

Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis

enthalten in: Artificial organs | 2015

von Krieter, D. | Fink, S. | Dorsch, O. | +4

3

Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preference

enthalten in: Seminars in thrombosis and hemostasis | 2015

von Zolfaghari, S. | Harenberg, J. | Frölich, L. | +7

4

The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation

enthalten in: Seminars in thrombosis and hemostasis | 2015

von Prandoni, P. | Lensing, A. | Prins, M. | +9

5

Determination of direct oral anticoagulants from human serum samples

enthalten in: Seminars in thrombosis and hemostasis | 2014

von Harenberg, J. | Kraemer, S. | Du, S. | +4

6

Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model

enthalten in: Clinical pharmacokinetics | 2013

von Abduljalil, K. | Lazar, S. | Natanzon, M. | +11

7

A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study

enthalten in: BMC nephrology | 2012

von Dorsch, O. | Krieter, D. | Lemke, H. | +5

8

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women

enthalten in: Thrombosis and haemostasis | 2007

von Bauersachs, R. | Dudenhausen, J. | Faridi, A. | +11

CommentIn: Thromb Haemost. 2007 Dec;98(6):1155-6. - PMID 18064306

9

Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin

enthalten in: Haematologica | 2003

von Harenberg, J. | Riess, H. | Büller, H. | +3

10

Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis

enthalten in: Thrombosis and haemostasis | 2003

von Riess, H. | Koppenhagen, K. | Tolle, A. | +10

CommentIn: Thromb Haemost. 2003 Aug;90(2):165-6. - PMID 12888863